In 1999, Dr Alphey took this groundbreaking idea to the University’s
wholly-owned technology transfer company, Isis Innovation. The
scientific and commercial expertise of its staff enabled him to work
through all the stages necessary to turn the idea into reality: first
protecting the intellectual property (IP), then, with fellow zoologist
Dr David Kelly, finding investors and in 2002 setting up a company.
That spin-out company – Oxitec (Oxford Insect Technologies), now based
in Milton Park, Abingdon – has recently been selected as one of 39
visionary ‘Technology Pioneers’ by the World Economic Forum because of
its potential contribution to reducing the incidence of debilitating
and widespread insect-borne diseases such as dengue fever, and limiting
the devastating damage to crops caused by fruit flies and other pests.
‘Isis does a genuinely useful thing that would be hard to do any other
way,’ says Dr Alphey. ‘Getting all the parties together, finding
individual investors and potential managers - there’s no way an
individual academic would be able to find them, without the
coordinating role of Isis.’
Tom Hockaday, who joined Isis in
2000 as Director of Special Products and has been its Managing Director
since 2006, is proud to see companies, which he and his colleagues have
nurtured through their early stages grow into strong, independent
businesses.
Many products are health-related and include novel
ways to deliver drugs, a potential vaccine for tuberculosis, and using
mobile phone technology to monitor patients with long-term health
problems such as diabetes and high blood pressure. Other ideas address
environmental issues through, for example, the development of greener
fuels, the use of improved heating controls in buildings, and a way to
tackle the very serious problem of groundwater contamination by arsenic
in Bangladesh.